455 North Bernardo Avenue
Mountain View, CA 94043
United States
650-237-2700
https://www.neuropace.com
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 171
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Joel D. Becker | CEO, President & Director | 762k | N/A | 1968 |
Ms. Rebecca L. Kuhn | CFO, VP of Finance & Administration, Corporate Secretary and Assistant Secretary | 614,91k | N/A | 1961 |
Dr. Martha J. Morrell | Chief Medical Officer | 728,68k | N/A | 1957 |
Ms. Leah Akin | Acting General Counsel | N/A | N/A | N/A |
Ms. Kelley Nicholas | Vice President of Sales | N/A | N/A | N/A |
Ms. Irene Thomas | Vice President of Human Resources | N/A | N/A | 1969 |
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
NeuroPace, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.